Fremanezumab Managed Access Program for Pediatric Patients
Clinical trial NCT03539393 · AVAILABLE
Trial details
- NCT number
- NCT03539393
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.